InvestorsHub Logo
Followers 733
Posts 75300
Boards Moderated 0
Alias Born 01/01/2012

Re: Midnightmatt post# 2363

Thursday, 10/12/2017 12:52:58 PM

Thursday, October 12, 2017 12:52:58 PM

Post# of 7464
Have you read the financials?

In the last 10-Q the revenue is only $1,571.

How is it that a pharmaceutical company only spends $68,172 on R&D for the quarter.

For the 9 months ending on May 31, 2017 we find:

"Net cash provided by financing activities = $3,782,356"

The we find:

"Proceeds from sale of common stock = $3,858,980"

"On January 5, 2017, the Company issued 5,055,334 shares to 13 investors at $.09 per share for a total of $449,573. Also on January 5, 2017, the Company issued 1,800,000 shares to 7 individuals who exercised their previous Warrant Rights at $.03 per share for a total of $54,000."

The company is being very generous to insiders.

I also noticed in the Assets that the company doesn't have any IP listed as a asset on the Balance Sheet.

IG

"Straight Facts Homey!"